Crossmark

PCSK9 inhibitors: Ratification of the role of LDL cholesterol in cardiovascular prevention. Towards a convergence of European and North American prevention guidelines?

Crossref DOI link: https://doi.org/10.1016/j.rceng.2019.05.005

Published Print: 2020-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Guijarro, C.

Camafort, M.
License Information

Text and Data Mining valid from 2020-08-01
More Information

This article is maintained by: Elsevier

Article Title: PCSK9 inhibitors: Ratification of the role of LDL cholesterol in cardiovascular prevention. Towards a convergence of European and North American prevention guidelines?

Journal Title: Revista Clínica Española (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rceng.2019.05.005

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.rce.2019.05.010

Content Type: article

Copyright: © 2019 Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). All rights reserved.

Document is current

Any future updates will be listed below